lobbying_activities: 3006801

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3006801	0de0ec95-27b3-407e-a4d3-551d9ef2021d	Q2	RICCHETTI INCORPORATED	62778	IPSEN BIOPHARMACEUTICALS, INC.	2023	second_quarter	PHA	Issues related to pharmaceutical industry, generally Issues related to development of products to treat limb spasticity and fibrodysplasia ossificans progressiva (FOP)	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2023-07-17T11:50:01-04:00